compounding semaglutide enforcement news On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, FDA crackdown on off-brand Ozempic

But what we are pretty much sure of now, which has been clarified over the past two decades or so, is there's a very very strong biological basis for developing obesity

Nicholas Perricone, world-renowned author of New York Times bestseller, The Wrinkle Cure

Effervescent formulas that already contain Vitamin C and Vitamin E offer convenience and enhanced efficacy

Consistent daily supplementation appears more beneficial than sporadic high-dose intake for sustained cognitive support

Peptide therapies are mailed directly to your doorstep so you can administer the treatments in the comfort and privacy of your own home

Tirzepatide may actually reduce UTI risk in diabetic patients by improving blood sugar control